As someone who played it during its early access period, I was immediately surprised by how much Grounded has evolved for its 1.0 launch. It feels like it’s not only fulfilled the potential of its ...
Introduction: Antihypertensive and psychotropic medications in same patient creates issues. Beta-blockers when co-administered with SSRIs/SNRIs, enzymes in the body, known as CYP450, can produce ...
I haven't taken a survey, but I feel pretty confident that nobody at PC Gamer is more afraid of spiders than I am. They petrify me—unless they manage to get on me, at which point I flail around like I ...
Q. I have been taking the antidepressant duloxetine for a long time, starting with brand-name Cymbalta. Ten years ago, I wanted to get off it, so my psychiatrist halved my dose to 30 milligrams. I ...
TNX-102 SL is the first new fibromyalgia treatment approved in over 15 years, joining three other treatments. Phase 3 trials showed significant pain reduction and good tolerance, with improvements in ...
Among 57,086 older adults, new gabapentin users demonstrated lower fall-related healthcare visits than duloxetine users, with a weighted cumulative incidence of 84.44 vs 158.21 per 1000 person-years ...
Bladder control problems, or urinary incontinence, can cause an uncontrolled urgency to urinate, increased visits to the bathroom, and accidental leakage. Different medical conditions, aging, and ...
Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Over 230,000 ...
The FDA has recalled more than 233,000 bottles of antidepressant duloxetine, sold by Rising Pharmaceuticals, due to a potential cancer risk. The recall, issued Dec. 5, was prompted by the discovery of ...
More than 233,000 bottles of an antidepressant have been recalled by public health officials due to a chemical containing the risk of cancer. The U.S. Food and Drug Administration classified capsules ...
More than 233,000 bottles of duloxetine, an antidepressant, are being recalled for containing a chemical that increases risk of cancer, the U.S. Food and Drug Administration announced. The FDA had ...
More than 233,000 bottles of the antidepressant duloxetine have been recalled because of a chemical that contains the risk of cancer, public health officials said. The U.S. Food and Drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback